Arama Sonuçları - Timothy C. Hardman

The future of clinical trials and drug development: 2050 Yazar: Timothy C Hardman, Rob Aitchison, Richard Scaife, Jean Edwards, Gill Slater, on behalf of the Committee of the Pharmaceutical Contract Management Group

Connect to this object online.

Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challenges Yazar: Charles Mundy, James Bush, Joseph Cheriyan, Ulrike Lorch, Steffan Stringer, Jörg Taubel, Kirsty Wydenbach, Timothy C. Hardman

Connect to this object online.

EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management Yazar: Luc Van Bortel, Hildegard Sourgens, Kerstin Breithaupt-Grögler, Henri Caplain, Yves Donazzolo, Ingrid Klingmann, Michael Hammond, Timothy C. Hardman, Steffan Stringer, Jan de Hoon

Connect to this object online.

The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges Yazar: Shahzadgai Khan, Muna Albayaty, James Bush, Joseph Cheriyan, Anthea Cromie, Annelize Koch, Michael Hammond, Stuart Mair, Ulrike Lorch, Steffan Stringer, Jorg Taubel, Timothy C. Hardman

Connect to this object online.

The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development Yazar: Susan Reijntjes, Muna Albayaty, James Bush, Joseph Cheriyan, Anthea Cromie, Annelize Koch, Michael Hammond, Stuart Mair, Peter Scholes, Ulrike Lorch, Steffan Stringer, Jorg Taubel, Timothy C. Hardman

Connect to this object online.

Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19 Yazar: Sergey V Efimov, Natallia V Matsiyeuskaya, Olga V Boytsova, Luydmila Yu Akhieva, Elena V Kuntsevich, Anastasia A Troshina, Elena I Kvasova, Anton A Tikhonov, Nadezhda F Khomyakova, Francisco Harrison, Jean-François Rossi, Timothy C Hardman

Connect to this object online.